Profile: Eli Lilly and Company develops a portfolio of pharmaceutical products. Our current marketed portfolio of medicines include reopro®, alimta®, gemzar®, humatrope®, cymbalta®, prozac®, strattera®, symbyax®, zyprexa®, evista®, forteo® and xigris®.